ENTITY
Eisai Co Ltd

Eisai Co Ltd (4523 JP)

241
Analysis
Health Care • Japan
Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.
more
•04 Aug 2020 06:48

🇯🇵 JAPAN • Results & Revisions 3rd August - Capcom, K's, Kikkoman, USS, Eisai

•BEST & WORST 3rd AUGUST •The 'best' and 'worst' from yesterday's large-cap announcements came from Kyorin (4569 JP) and Japan Airlines (9201...

Logo
501 Views
Share
•13 Jul 2020 14:39

🇯🇵 JAPAN • Stress Tests Part 6: Currency Risk

WHAT CURRENCY RISK? - It seems rather old-fashioned to raise the topic of currency risk in relation to potential stressors on Japanese listed...

Logo
521 Views
Share
•13 May 2020 07:18

🇯🇵 JAPAN • Results & Revisions 12th May - Secom, Shiseido, Toyota, Sysmex, Mitsui Fudosan

CASCADE - As expected, with many more of the larger listed companies reporting, our three Scores are falling in unison and at the fastest rate...

Logo
473 Views
Share
•19 Feb 2020 14:04

🇯🇵 JAPAN • IT’S A WRAP! Part 2: 2020-Q1 Results & Revision Scores

THREE-YEAR LOW - With Bridgestone (5108 JP)'s results and revision now added, our final tally for this season is a 196 basis point decline in our...

Logo
584 Views
Share
bullish•Otsuka Holdings
•09 Jun 2026 08:30

Otsuka Holdings (4578 JP): Voyxact Positive Trial Data Augur Well For the Future

​Otsuka presents positive 12-month eGFR data for Voyxact in Phase 3 trial. Regulatory submission likely in 2H26. New drugs like this to drive...

Logo
121 Views
Share
x